[Refractory cutaneous leishmaniasis: Benefit of miltefosine]

Med Mal Infect. 2019 Jun;49(4):281-283. doi: 10.1016/j.medmal.2018.11.009. Epub 2018 Dec 13.
[Article in French]
No abstract available

Keywords: Dermal leishmaniasis; Leishmania tropica; Leishmaniose cutanée; Miltefosine; Miltéfosine.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiprotozoal Agents / therapeutic use*
  • Drug Resistance* / drug effects
  • Humans
  • Leishmaniasis, Cutaneous / drug therapy*
  • Male
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine